#39 Insulet's CCO Shacey Petrovic Answers Your OmniPod Questions
My conversation with OmniPod CCO, Shacey Petrovic...
Episode 39 of the Juicebox Podcast is an hour long conversation with Insulet's Chief Commercial Officer Shacey Petrovic. Shacey answers questions from the diabetes community and from me in this candid chat. We talk about Medicare, Freestyle test strips, Artificial Pancreas, OmniPod/Dexcom partnerships, new PDM status, the Forbes piece that paints OmniPod as being in jeopardy of being "out of the insulin pump market" in one year and much more. One of your questions even makes it onto Shacey's action item list... Well done! BTW, I have a OmniPod t-shirt giveaway running from nov 24, 12am to dec 8, 12am... good luck!
Subscribe today on iTunes...
Show notes
Learn more about OmniPod by visiting their website.
Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad on Amazon.
The Juicebox Podcast will soon be available on Google Play!
Subscribe to the podcast on iTunes today!
*****
Freestyle Test Strip Info that Shacey spoke of...
OmniPod® patients now have access to a dedicated toll-free Helpline if they should experience any co-pay or coverage issues with their FreeStyle® Test Strips (877-654-9975). Upon dialing this number, the patient will reach a knowledgeable customer support team member to help them navigate through their test strip coverage.
As of November 2nd, patients who call the support number will also be offered the Prior Authorization Assistance Program (PAAP). The goal of the PAAP is to ensure easy access to FreeStyle test strips for new (and existing) OmniPod patients. With patient consent and HIPAA authorization, the following steps will be taken to execute on the PAAP:
1. Abbott will conduct a full Benefit Investigation.
2. From there, Abbott will both facilitate/assist in reaching out to the patient's payers and HCP to obtain the Prior Authorization (Appeal or Tier Exception) approval.
3. If approved, Abbott will be sending the PA approval and Rx referral to the patient's pharmacy of choice.
4. If denied, Abbott will be driving patients to participating pharmacies (major retail chains). Eligible patients may be able to benefit/receive automatic and affordable co-pay savings at participating pharmacies.
